Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
588.00    13.00 (2.26%)
Bid:
585.00
Ask:
587.00
Spread: 2.00 (0.342%)
Market Cap: £512.29m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Director/PDMR Shareholding

10 Feb 2023 14:12

RNS Number : 6220P
Victrex PLC
10 February 2023
 

10 February 2023

Victrex plc (the Company)

Grant of Options under the Victrex plc 2015 UK Sharesave Plan

Notification of transactions by directors/persons discharging managerial responsibilities

Victrex plc announces that it has launched two 2023 Save As You Earn Schemes (the "SAYE Scheme"). The SAYE Scheme is an all-employee scheme which gives the opportunity to eligible UK employees to acquire shares at a discount, over 3 or 5 years.

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 1p each ("Shares"), with an exercise price of £13.936 per share representing a 20% discount to the closing mid-market price on 11 January 2023, the day before the invitation to participate was made. The exercise price was calculated in accordance with the rules of the SAYE. The options have a savings start date of 1 April 2023 and will normally be exercisable for 6 month period commencing 1 April 2026 for the 3 Year contract, and 1 April 2028 for the 5 Year contract.

A total of 463 employees elected to participate in the 2023 SAYE Scheme accordingly a total of 374,055 options were granted on 9 February 2023. In consideration of these options, the grantees will make monthly savings during the associated savings contract.

The following Persons Discharging Managerial Responsibility ("PDMRs") have chosen to participate in the 2023 SAYE Scheme:

Name

Position

No. of shares under options granted

Savings Contract Period

Jakob Sigurdsson

Executive Director

2,152

5 Years

Martin Court

Executive Director

645

3 Years

Ian Melling

Executive Director

1,291

3 Years

 

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below and gives further details on the option grants for directors and PDMRs.

  

 

 

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1.  Jakob Sigurdsson

2.  Martin Court

3.  Ian Melling

2

Reason for the notification

a)

Position/status

Executive Director (PDMR)

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Victrex plc

b)

LEI

213800UYNPHAUNHPXL67

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Option over ordinary shares of 1p each

 

 

GB0009292243

b)

Nature of the transaction

Option granted under the Company's all-employee HMRC approved Save As You Earn scheme (Victrex plc 2015 UK Sharesave Plan) with an exercise price of £13.936.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.

£13.936

2,152

2.

£13.936

645

3.

£13.936

1,291

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

N/A

 

e)

Date of the transaction

9 February 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGMZDGMGFZM
Date   Source Headline
17th Mar 20152:28 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSAdditional Listing
27th Feb 201510:00 amRNSTotal Voting Rights
26th Feb 20154:53 pmRNSHolding(s) in Company
25th Feb 20154:43 pmRNSHolding(s) in Company
19th Feb 20153:03 pmRNSDirector/PDMR Shareholding
17th Feb 20152:25 pmRNSDirector/PDMR Shareholding
4th Feb 20153:59 pmRNSResult of AGM
4th Feb 20157:00 amRNSAGM and Q1 Interim Management Statement
30th Jan 20152:00 pmRNSTotal Voting Rights
26th Jan 201512:03 pmRNSDirector Declaration
19th Jan 20153:38 pmRNSDirector/PDMR Shareholding
14th Jan 20154:00 pmRNSHolding(s) in Company
5th Jan 201511:43 amRNSAnnual Financial Report
31st Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20147:00 amRNSDirector Declaration
18th Dec 20148:34 amRNSDirectorate Change
18th Dec 20147:00 amRNSDirectorate Change
17th Dec 201412:45 pmRNSDirector/PDMR Shareholding
16th Dec 20145:13 pmRNSDirector/PDMR Shareholding
16th Dec 20144:43 pmRNSDirector/PDMR Shareholding
9th Dec 20147:00 amRNSFinal Results
1st Dec 20141:51 pmRNSBlocklisting Interim Review
28th Nov 201410:00 amRNSTotal Voting Rights
25th Nov 20144:30 pmRNSHolding(s) in Company
18th Nov 201411:38 amRNSDirector/PDMR Shareholding
6th Nov 201411:12 amRNSDirector Declaration
31st Oct 20149:27 amRNSTotal Voting Rights
21st Oct 20143:14 pmRNSSenior Independent Director Appointment
20th Oct 20144:38 pmRNSHolding(s) in Company
20th Oct 20149:05 amRNSDirector/PDMR Shareholding
9th Oct 20147:00 amRNSTrading Statement
1st Oct 20143:56 pmRNSDirector Disclosure Section 430 (2B)
1st Oct 20147:00 amRNSDirectorate Change
30th Sep 20141:34 pmRNSTotal Voting Rights
24th Sep 20144:12 pmRNSHolding(s) in Company
17th Sep 20141:16 pmRNSDirector/PDMR Shareholding
29th Aug 201410:00 amRNSTotal Voting Rights
19th Aug 20142:34 pmRNSDirector/PDMR Shareholding
31st Jul 20149:37 amRNSTotal Voting Rights
30th Jul 20147:00 amRNSInterim Management Statement
21st Jul 20142:13 pmRNSHolding(s) in Company
30th Jun 20142:54 pmRNSTotal Voting Rights
27th Jun 20144:00 pmRNSHolding(s) in Company
23rd Jun 201411:07 amRNSHolding(s) in Company
17th Jun 20144:04 pmRNSDirector/PDMR Shareholding
9th Jun 201411:18 amRNSBlocklisting Interim Review
4th Jun 20142:28 pmRNSDirector/PDMR Shareholding
30th May 201412:00 pmRNSTotal Voting Rights
27th May 20143:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.